Angiodynamics (ANGO) Return on Equity (2011 - 2026)

Angiodynamics (ANGO) has 16 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Feb 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
• Across five years, Return on Equity topped out at 0.0% in Q3 2023 and bottomed at 0.01% in Q3 2024.
• The 5-year median for Return on Equity is 0.0% (2025), against an average of 0.0%.
• The widest annual swing landed in 2024, when Return on Equity slipped 1 bps; it then gained 1 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then surged by 57 bps to 0.0% in 2023, then tumbled by 3343 bps to 0.01% in 2024, then surged by 87 bps to 0.0% in 2025, then slipped by 15 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison